Predictions
United Therapeutics
Start price
Target price
Perf. (%)
€112.26
05.04.17
05.04.17
€150.63
05.10.17
05.10.17
-1.81%
05.10.17
05.10.17
Five Prime Therapeutics
Start price
Target price
Perf. (%)
€33.29
03.04.17
03.04.17
€40.59
20.10.17
20.10.17
25.79%
20.10.17
20.10.17
Recro Pharma Inc.
Start price
Target price
Perf. (%)
€6.89
22.03.17
22.03.17
€19.00
04.11.21
04.11.21
-76.20%
05.11.21
05.11.21
TherapeuticsMD Inc.
Start price
Target price
Perf. (%)
€320.35
18.03.17
18.03.17
€600.00
27.09.17
27.09.17
-30.72%
27.09.17
27.09.17
Meta Platforms Inc.
Start price
Target price
Perf. (%)
€125.75
14.03.17
14.03.17
€135.30
24.03.17
24.03.17
0.88%
24.03.17
24.03.17
Neos Therapeutics Inc
Start price
Target price
Perf. (%)
€6.31
10.03.17
10.03.17
€10.10
26.10.17
26.10.17
44.29%
26.10.17
26.10.17
F-Star Therapeutics Inc.
Start price
Target price
Perf. (%)
€39.51
05.03.17
05.03.17
€86.59
06.09.17
06.09.17
37.53%
06.09.17
06.09.17
Loxo Oncology Inc
Start price
Target price
Perf. (%)
€40.59
05.03.17
05.03.17
€45.10
05.06.17
05.06.17
62.16%
05.06.17
05.06.17
Berkshire Hathaway Inc. B
Start price
Target price
Perf. (%)
€154.15
28.02.17
28.02.17
€167.77
28.08.17
28.08.17
4.65%
28.08.17
28.08.17
Micron Technology Inc.
Start price
Target price
Perf. (%)
€21.27
27.02.17
27.02.17
€98.00
22.10.24
22.10.24
183.32%
22.07.22
22.07.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Undervalued
Low dividend yield expected
GNC Holdings Inc. A
Start price
Target price
Perf. (%)
€7.68
06.02.17
06.02.17
€11.46
07.08.17
07.08.17
17.39%
07.08.17
07.08.17
Berkshire Hathaway Inc. B
Start price
Target price
Perf. (%)
€152.33
03.02.17
03.02.17
€158.00
14.02.17
14.02.17
3.79%
14.02.17
14.02.17
Top Rating
Very positive Cash Flow expected
Fair valuation
Very capable Management